-DOCSTART- -X- O
BACKGROUND -X- _ O
: -X- _ O
Results -X- _ O
from -X- _ O
cohort -X- _ O
studies -X- _ O
evaluating -X- _ O
the -X- _ O
severity -X- _ O
of -X- _ O
respiratory -X- _ B-Intervention
viral -X- _ I-Intervention
co- -X- _ I-Intervention
infections -X- _ I-Intervention
are -X- _ O
conflicting. -X- _ O
We -X- _ O
conducted -X- _ O
a -X- _ O
systematic -X- _ O
review -X- _ O
and -X- _ O
meta-analysis -X- _ O
to -X- _ O
assess -X- _ O
the -X- _ O
clinical -X- _ O
severity -X- _ O
of -X- _ O
viral -X- _ B-Intervention
co-infections -X- _ I-Intervention
as -X- _ O
compared -X- _ O
to -X- _ O
single -X- _ B-Comparison
viral -X- _ I-Comparison
respiratory -X- _ I-Comparison
infections. -X- _ I-Comparison
METHODS -X- _ O
: -X- _ O
We -X- _ O
searched -X- _ O
electronic -X- _ O
databases -X- _ O
and -X- _ O
other -X- _ O
sources -X- _ O
for -X- _ O
studies -X- _ O
published -X- _ O
up -X- _ O
to -X- _ O
January -X- _ O
28 -X- _ O
, -X- _ O
2013. -X- _ O
We -X- _ O
included -X- _ O
observational -X- _ O
studies -X- _ O
on -X- _ O
inpatients -X- _ O
with -X- _ O
respiratory -X- _ O
illnesses -X- _ O
comparing -X- _ O
the -X- _ O
clinical -X- _ O
severity -X- _ O
of -X- _ O
viral -X- _ B-Intervention
co-infections -X- _ I-Intervention
to -X- _ O
single -X- _ B-Comparison
viral -X- _ I-Comparison
infections -X- _ I-Comparison
as -X- _ O
detected -X- _ O
by -X- _ O
molecular -X- _ O
assays. -X- _ O
The -X- _ O
primary -X- _ O
outcome -X- _ O
reflecting -X- _ O
clinical -X- _ O
disease -X- _ O
severity -X- _ O
was -X- _ O
length -X- _ O
of -X- _ O
hospital -X- _ O
stay -X- _ O
( -X- _ O
LOS -X- _ O
) -X- _ O
. -X- _ O
A -X- _ O
random-effects -X- _ O
model -X- _ O
was -X- _ O
used -X- _ O
to -X- _ O
conduct -X- _ O
the -X- _ O
meta-analyses. -X- _ O
RESULTS -X- _ O
: -X- _ O
Twenty-one -X- _ O
studies -X- _ O
involving -X- _ O
4,280 -X- _ B-Patient
patients -X- _ I-Patient
were -X- _ O
included. -X- _ O
The -X- _ O
overall -X- _ O
quality -X- _ O
of -X- _ O
evidence -X- _ O
applying -X- _ O
the -X- _ O
GRADE -X- _ O
approach -X- _ O
ranged -X- _ O
from -X- _ O
moderate -X- _ B-Outcome
for -X- _ I-Outcome
oxygen -X- _ I-Outcome
requirements -X- _ I-Outcome
to -X- _ I-Outcome
low -X- _ I-Outcome
for -X- _ I-Outcome
all -X- _ I-Outcome
other -X- _ I-Outcome
outcomes. -X- _ I-Outcome
No -X- _ I-Outcome
significant -X- _ I-Outcome
differences -X- _ I-Outcome
in -X- _ I-Outcome
length -X- _ I-Outcome
of -X- _ I-Outcome
hospital -X- _ I-Outcome
stay -X- _ I-Outcome
( -X- _ I-Outcome
LOS -X- _ I-Outcome
) -X- _ I-Outcome
( -X- _ I-Outcome
mean -X- _ I-Outcome
difference -X- _ I-Outcome
( -X- _ I-Outcome
MD -X- _ I-Outcome
) -X- _ I-Outcome
−0.20 -X- _ I-Outcome
days -X- _ I-Outcome
, -X- _ I-Outcome
95 -X- _ I-Outcome
% -X- _ I-Outcome
CI -X- _ I-Outcome
−0.94 -X- _ I-Outcome
, -X- _ I-Outcome
0.53 -X- _ I-Outcome
, -X- _ I-Outcome
p -X- _ I-Outcome
= -X- _ I-Outcome
0.59 -X- _ I-Outcome
) -X- _ I-Outcome
, -X- _ I-Outcome
or -X- _ I-Outcome
mortality -X- _ I-Outcome
( -X- _ I-Outcome
RR -X- _ I-Outcome
2.44 -X- _ I-Outcome
, -X- _ I-Outcome
95 -X- _ I-Outcome
% -X- _ I-Outcome
CI -X- _ I-Outcome
0.86 -X- _ I-Outcome
, -X- _ I-Outcome
6.91 -X- _ I-Outcome
, -X- _ I-Outcome
p -X- _ I-Outcome
= -X- _ I-Outcome
0.09 -X- _ I-Outcome
) -X- _ I-Outcome
were -X- _ I-Outcome
documented -X- _ I-Outcome
in -X- _ I-Outcome
subjects -X- _ I-Outcome
with -X- _ I-Outcome
viral -X- _ I-Outcome
co-infections -X- _ I-Outcome
compared -X- _ I-Outcome
to -X- _ I-Outcome
those -X- _ I-Outcome
with -X- _ I-Outcome
a -X- _ I-Outcome
single -X- _ I-Outcome
viral -X- _ I-Outcome
infection. -X- _ I-Outcome
There -X- _ I-Outcome
was -X- _ I-Outcome
no -X- _ I-Outcome
evidence -X- _ I-Outcome
for -X- _ I-Outcome
differences -X- _ I-Outcome
in -X- _ I-Outcome
effects -X- _ I-Outcome
across -X- _ I-Outcome
age -X- _ I-Outcome
subgroups -X- _ I-Outcome
in -X- _ I-Outcome
post -X- _ I-Outcome
hoc -X- _ I-Outcome
analyses -X- _ I-Outcome
with -X- _ I-Outcome
the -X- _ I-Outcome
exception -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
higher -X- _ I-Outcome
mortality -X- _ I-Outcome
in -X- _ I-Outcome
preschool -X- _ I-Outcome
children -X- _ I-Outcome
( -X- _ I-Outcome
RR -X- _ I-Outcome
9.82 -X- _ I-Outcome
, -X- _ I-Outcome
95 -X- _ I-Outcome
% -X- _ I-Outcome
CI -X- _ I-Outcome
3.09 -X- _ I-Outcome
, -X- _ I-Outcome
31.20 -X- _ I-Outcome
, -X- _ I-Outcome
p -X- _ I-Outcome
< -X- _ I-Outcome
0.001 -X- _ I-Outcome
) -X- _ I-Outcome
with -X- _ I-Outcome
viral -X- _ I-Outcome
co- -X- _ I-Outcome
infection -X- _ I-Outcome
as -X- _ I-Outcome
compared -X- _ I-Outcome
to -X- _ I-Outcome
other -X- _ I-Outcome
age -X- _ I-Outcome
groups -X- _ I-Outcome
( -X- _ I-Outcome
I -X- _ I-Outcome
( -X- _ I-Outcome
2 -X- _ I-Outcome
) -X- _ I-Outcome
for -X- _ I-Outcome
subgroup -X- _ I-Outcome
analysis -X- _ I-Outcome
64 -X- _ I-Outcome
% -X- _ I-Outcome
, -X- _ I-Outcome
p -X- _ I-Outcome
= -X- _ I-Outcome
0.04 -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ O
CONCLUSIONS -X- _ O
: -X- _ O
No -X- _ B-Outcome
differences -X- _ I-Outcome
in -X- _ I-Outcome
clinical -X- _ I-Outcome
disease -X- _ I-Outcome
severity -X- _ I-Outcome
between -X- _ I-Outcome
viral -X- _ I-Outcome
co-infections -X- _ I-Outcome
and -X- _ I-Outcome
single -X- _ I-Outcome
respiratory -X- _ I-Outcome
infections -X- _ I-Outcome
were -X- _ I-Outcome
documented. -X- _ I-Outcome
The -X- _ O
suggested -X- _ O
increased -X- _ B-Outcome
risk -X- _ I-Outcome
of -X- _ I-Outcome
mortality -X- _ I-Outcome
observed -X- _ I-Outcome
amongst -X- _ I-Outcome
children -X- _ I-Outcome
with -X- _ I-Outcome
viral -X- _ I-Outcome
co-infections -X- _ I-Outcome
requires -X- _ O
further -X- _ O
investigation -X- _ O
. -X- _ O

